 Home > Biochemical Engineering > Polypeptide > Lecirelin for Sale > Lanreotide Acetate 61012-19-9 is a long-acting somatostatin analog for acromegaly and GEP-NETs

Lanreotide Acetate 61012-19-9 is a long-acting somatostatin analog for acromegaly and GEP-NETs buy - large image1

Lanreotide Acetate 61012-19-9 is a long-acting somatostatin analog for acromegaly and GEP-NETs

Name: Lanreotide Acetate 61012-19-9 is a long-acting somatostatin analog for acromegaly and GEP-NETs
Brand: focuses
SKU: pr2508291432
Price: 1 USD
Availability: InStock

Unit Price: Get Latest Price 

CAS No.:

61012-19-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ningbo

Brand:

focuses

Packaging:

as requires

Price valid (until):

2025-09-29

Contact Supplier

 Chat Now

Fujian Genohope Biotech Ltd.

Company Type:

Manufactory

Location:

China

Payment Terms:

TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

Average Lead Time:

2 days

Qualification:

Main Products:

Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Cagrilintide,PLLA facial Implant

 Visit Store

Product Description
Seller Information

Description

Product Detail

1. Common Name: Lanreotide acetate
2. International Common Name (US): Lanreotide acetate
3. CAS: 61012-19-9
4. Batch size: lab-scale: 10-20 g; pilot scale: 100-200g (not in pilot workshop)
5. Classification: Somatostatin analogues
6. Indication: mainly used for the treatment of acromegaly and neuroendocrine tumors
7. Storage condition: Store in a dark, sealed container at -20±5℃.
8. Package: two layers LDPE bags with desiccant and aluminium foil bag.
9. Retest: Not decided yet

Our Factory

Fujian Genohope Biotech Ltd was established in 2019, It was co-founded by New Hope Hosencare Brothers and Taiwan Genovior Biotech Corporation. The company is located in the national "Cross-Strait Biotechnology and Health and Medical Industry Cooperation Zone" in Putian City, Fujian Province. The company has 260 employees, and in 2023, the company was selected as a Specialized in special innovative enterprises in Fujian Province.

The company focuses on High potency polypeptide API/solution, and sells polypeptide API/solution and preparation production services to the global market. The company covers a total area of 55 mu, with a total construction area of about 70,000 square meters, and has built about 800 square meters of R & D center, 1,000 square meters of quality control center and 3,300 square meters of GMP production workshop. At present, 13 production lines have been built, including 7 production lines for the preparation of recombinant peptide API and fully synthetic peptide API and 6 lines for injections. In addition, the company also has a large anti-tumor injection workshop, a small multi-purpose injection workshop, a large multi-purpose injection workshop. The construction and operation management of the production line meet the regulatory requirements of the global drug market and meet the double registration and declaration of China and the United States. Also can meet the customer registration and sales at home and abroad.

Product superiority：

At present, the company's main products are Semaglutide, Tirzepatide, Retatrutide, cosmetic medicine microspheres, collagen. In particular, the company has the advantage of mature 2 processes preparation of Semaglutide API, Semaglutide API registered in the US FDA (DMF No. : 040957),Tirzepatide API registered in the US FDA (DMF No. : 040503),

Semaglutide API has the following three characteristics: low price, high quality, and large production capacity (tonnage). Tirzepatide API is well received favourable reviews in the pharmaceutical industry of polypeptide .

Our Certificate

FAQ

Q: What does semaglutide do to your body?

A: Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy.

Q: What is the dark side of semaglutide?

A: Pancreatitis (swelling of the pancreas) may occur while you are using this medicine. Check with your doctor right away if you have sudden and severe stomach pain, chills, constipation, nausea, vomiting, fever, or lightheadedness.

Q: Who cannot take semaglutide?

A: Thyroid cancer or if someone in your family had thyroid cancer. An unusual or allergic reaction to semaglutide, other medications, foods, dyes, or preservatives. Pregnant or trying to get pregnant. Breast-feeding.

Q: Why do I feel so bad on semaglutide?

A: However, semaglutide also affects the gastrointestinal tract by increasing the amount of glucagon. This has two effects on the digestive tract. First, it slows down the movement of food through your gut, which can lead to nausea, vomiting, and diarrhea.

Q: Can semaglutide be harmful?

A: Nausea, vomiting, and diarrhea are the most common semaglutide side effects. But they usually subside after a few weeks of using the medication. Although rare, serious side effects are possible. Some may require immediate medical attention, such as pancreatitis and allergic reactions.

Q: Can semaglutide damage your pancreas?

A: Does Semaglutide Damage Your Pancreas? Semaglutide has been associated with pancreatitis, which is an inflammation of the pancreas. While pancreatitis can cause damage to the pancreas, the occurrence of this side effect due to semaglutide is considered uncommon.

Q: Can I lose 50 lbs on semaglutide?

A: According to clinical trials, people on a weekly semaglutide dosage can expect to lose an average of 5–10% of their body weight. Patients who were overweight lost 5.9% of their body weight after three months of weekly semaglutide injections. The average weight loss was 10.9% after 6 months of weekly injections.

Q: Is metformin as good as semaglutide?

A: Between these two medications, semaglutide produces more significant weight loss than metformin, but metformin tends to be a more affordable option. But patients can also opt to combine these drugs to maximize their effects with a proper treatment plan.

ECHEMI Editorial Reference

Lecirelin, a synthetic gonadotropin-releasing hormone (GnRH) analog, acts as a GnRH agonist. Lecirelin is widely used for the research of bovine ovarian follicular cysts. lecithin and buserelin, two nonapeptides, are used as the acetate. Lecirelin differs by substitution of D-tertiary leucine for glycine at position 6 and the replacement of glycine by ethylamide at position 10. Buserelin has a D-serine at position 6 and ethylamide at position 10.

Basic Info

Product Name:
Lecirelin

Other Name:
SUPERGESTRAN(TM);PYR-HIS-TRP-SER-TYR-TBU-D-GLY-LEU-ARG-PRO-NHET;Lecirelin(6-(3-methyl-D-valine)-9-(N-ethyl-L-prolynamide)-10-deglycinamide);(DES-GLY10,TBU-D-GLY6,PRO-NHET9)-LHRH;(D-TLE6)-LEUPROLIDE;(D-TLE6)-LEUPRORELIN;[D-TLE6,PRO-NHET9]-LHRH;GLP-HIS-TRP-SER-TYR-TLE-LEU-ARG-PRO-NHET

CAS No.:
61012-19-9

Molecular Formula:
C59H84N16O12

InChIKeys:
XJWIEWPGHRSZJM-JUAATNMYNA-N

Molecular Weight:
1209.42

EC Number:
200-001-8

Color/Form:
White to off-white

Categories:
Polypeptide

Characteristics

Density:
1.44

PKA:
9.82±0.15(Predicted)

Critical Temperature & Pressure:
Store at -20°C
Seller Information

Business Type:
Manufactory

Main Products:
Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Cagrilintide,PLLA facial Implant

Location:
NO.288,Renyang, Binglun Village, Hushi Town, Xiuyu DistrictPutian City, Fujian Province 351146, China (CHN)

Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
2 days

Total Annual Revenue:
$25 million-$50 million

Total Employees:
201-300

Year of Establishment:
2019

Company Certificates
- DMF ACKNOWLEDGEMENT
- Notice of GMP Compliance Inspection
Company Profile

Fujian Genohope Biotech Ltd., is founded by New Hope Group, a Fortune Global 500 company, together with Genovior, fomous Taiwan peptide company and now a member of the Polaris Pharma Group, as the globalized center for R&D and production of peptide products, located in the National Biotech and Health Industry Zone of Across-Strait in Putian City, Fujian Province.

The company focuses on the research and development and production of high potency polypeptide products, targeting the global market, and provides polypeptide API/raw material and preparation products. It has built polypeptide API workshops, bio-fermentation workshops, polypeptide purification and lyophilization workshops, and multifunctional injection workshops that meet the GMP requirements of mainstream markets such as the U.S. FDA, EU EMA, Japanese PMDA, and China NMPA. With the strong support of New Hope Group, the company has introduced advanced large-scale CS-PREP® industrial preparative liquid chromatography systems, becoming one of the few polypeptide companies in the industry with a capacity of tons.

In 2023, Genehope has been rewarded as Specialized and Novel Enterprise of Fujian Province.
In 2023 June, the US FDA completed its first on-site inspection for Genohope.
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
CAS 61012-19-9 Lecirelin Raw Material	Pharmaceutical Grade/99		Fulecare	Inquiry
Lecirelin	/99.00		HANGZHOU LEAP CHEM CO., LTD.	Inquiry
Concessional High Quality LECIRELIN 99% White powder High Quality from China	Pharmaceutical Grade/99		Jinshu Peptide Co.,Ltd	Inquiry
Lecirelin Acetate 98% white powder / Youngshe CAS:61012-19-9	Chemical Grade/98	$20-25/UNIT FOB	Youngshe	Inquiry
White Powder Lecirelin 61012-19-9	Pharmaceutical Grade/99		Changzhou Xuanming Pharmaceutical Techno	Inquiry

Lanreotide Acetate 61012-19-9 is a long-acting somatostatin analog for acromegaly and GEP-NETs

Product Description

Seller Information

Our Factory

Our Certificate

More Choices Find All Products for Sale 

Related Searches

More from this Seller